Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies

Gregory J. Kubicek, Rita S. Axelrod, Mitchell MacHtay, Peter H. Ahn, Pramila R. Anne, Shannon Fogh, David Cognetti, Thomas J. Myers, Walter J. Curran, Adam P. Dicker

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint Dive into the research topics of 'Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy